CLL Society wants to hear from you. Part of our organization’s mission is to increase patient education and research. We need your support to increase the body of knowledge for patients and caregivers affected by CLL. Please see current surveys below that help us aggregate information on a variety of topics to inform our field and CLL Society, so we can better serve this community.
We want to hear from you! Please click here to answer three short questions that will help CLL Society gain a better understanding of what areas of CLL research are most important to those we serve.
How much do you know about the critical tests which can predict which patients will do well on or fail certain medications? Prognostic testing should be done before each and every treatment decision; share your experience and test your knowledge by completing the Test Before Treat Survey!
If you read the CLL Society Tribune, our quarterly newsletter, we want to hear from you! How can we improve the quarterly newsletter? What sections are most popular with our readers? Please take a moment to complete this brief evaluation; your feedback is important!
CAR-T (Chimeric Antigen Receptor-T cell) therapy is an exciting cellular immunotherapy with the potential to treat many cancers including chronic lymphocytic leukemia (CLL) and lymphomas. Please take a moment to complete our very brief, reader survey covering CAR-T Therapy. We will share the results in our March 2020 CLL Society Tribune.
CLL Society is exploring how treatment decisions are being made in the doctor’s office. If you are a CLL patient, please take a moment to complete our very brief, reader survey. We will share the results in our June 2021 CLL Society Tribune.
The CLL Society is periodically asked to help recruit CLL patients for surveys. For more information click here.